Transasia Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.00 M
as on 13-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 18.90%
(FY 2024)
- Profit -300.81%
(FY 2024)
- Ebitda -78.67%
(FY 2024)
- Net Worth -36.06%
(FY 2024)
- Total Assets 53.87%
(FY 2024)
About Transasia Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Vazirani, Mala Vazirani, Sunil Vazirani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299MH2020PTC344692
- Company No.
344692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Transasia Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Vazirani  | Director | 26-Aug-2020 | Current |
| Mala Vazirani | Director | 26-Aug-2020 | Current |
| Sunil Vazirani | Additional Director | 01-Apr-2024 | Current |
| Vibhuti Vazirani | Director | 23-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Transasia Diagnostics.
Transasia Diagnostics Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 18.9% increase. The company also saw a substantial fall in profitability, with a 300.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 36.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Transasia Diagnostics?
In 2023, Transasia Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Transasia Bio-Medicals LimitedActive 39 years 7 monthsSuresh Vazirani, Mala Vazirani and 2 more are mutual person
- Transasia Instruments LimitedActive 36 years 7 months
Suresh Vazirani and Mala Vazirani are mutual person
- Transasia Diagnostics Solutions LimitedActive 5 years 8 months
Suresh Vazirani, Mala Vazirani and 1 more are mutual person
Taipan Sea Foods LimitedActive 21 years 2 monthsSuresh Vazirani and Mala Vazirani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Transasia Diagnostics?
Transasia Diagnostics has a workforce of 38 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Transasia Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transasia Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
